STEINMAN LAWRENCE

CIK: 0001132679
Director

STEINMAN LAWRENCE is a corporate insider at Pasithea Therapeutics Corp. (KTTA) filing SEC Form 4 transactions. 47 transactions across 5 companies, totaling $197,396 in purchases and $330,485 in sales. Source: SEC EDGAR.

Total Transactions
47
Total Buy Value
$197K
Total Sell Value
$330K
Net Activity
$-133K
Last Transaction
Nov 2025
Companies
5

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Purchase
Shares
133,333
Price
$0.75
Value
$100K
Type
Award
Shares
242,913
Price
-
Value
-
180 Life Sciences Corp.
ATNF
Type
Award
Shares
110,000
Price
-
Value
-
180 Life Sciences Corp.
ATNF
Type
Award
Shares
44,959
Price
-
Value
-
180 Life Sciences Corp.
ATNF
Type
Award
Shares
110,000
Price
-
Value
-
180 Life Sciences Corp.
ATNF
Type
Award
Shares
48,198
Price
-
Value
-
Type
Award
Shares
23,500
Price
-
Value
-
180 Life Sciences Corp.
ATNF
Type
Award
Shares
65,000
Price
-
Value
-
Type
Award
Shares
16,500
Price
-
Value
-
Type
Award
Shares
7,500
Price
-
Value
-
Type
Award
Shares
7,500
Price
-
Value
-
Type
Purchase
Shares
20,000
Price
$2.05
Value
$41K
180 Life Sciences Corp.
ATNF
Type
Award
Shares
15,000
Price
$0.00
Value
$0
Type
Award
Shares
50,000
Price
$0.00
Value
$0
Type
Purchase
Shares
30,000
Price
$0.43
Value
$13K
180 Life Sciences Corp.
ATNF
Type
Purchase
Shares
18,000
Price
$1.23
Value
$22K
Type
Award
Shares
5,000
Price
$0.98
Value
$5K
Type
Award
Shares
5,000
Price
$0.99
Value
$5K
Type
Award
Shares
5,000
Price
$1.10
Value
$6K
Type
Award
Shares
9,000
Price
$1.13
Value
$10K